Small Molecular Medicines Market Analysis
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (1 June 2021) | Viewed by 471
Special Issue Editors
Interests: medicines optimization; medicine utilization; academic detailing; clinical simulation and avatars
Special Issue Information
Dear Colleagues,
The market for “small molecular medicines” continues to grow, because of the combination of the increasing use of these medicines to treat acute and chronic diseases, and the increasing needs of an ageing population.
Health spending worldwide is increasing above the allocated resources, putting pressure on the health sector’s budget. Medicine utilization studies, usually small molecular medicine market analyses, provide insights that allow policy makers, budget holders, and healthcare professionals to support them to provide prompt access to effective treatments when appropriate, to make sure that spending on medicines is affordable for the health sector, and to support innovation in long-term medicines by promoting a thriving and sustainable pharmaceutical sector.
We invite you to share your approaches and experiences in analyzing the small medicine(s) market at the institutional (primary/secondary care sectors), national, and international level regarding a medicine, a group of medicines, or even the entire array of medicines utilized over a period of time and the financial impact of their analyses. We hope this Special Issue will inspire other healthcare professionals to share their own analyses, adopt new approaches, and innovate to make improvements.
Prof. Dr. Stephen ChapmanDr. Mohammed I. Aladul
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Small molecular medicines;
- Conventional medicines
- Market
- Utilization
- Analysis
- Budget
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
